India's mobile production has surged by 146%, reaching ₹5.25 lakh crore by FY 2024-25, with exports increasing by 775%.

The proposed MIP is reportedly seen as a crucial move to support the local pharma industry and reduce dependency on China, ...

The government has banned the use of 18 antibiotics, 18 antivirals, and one anti-protozoan in egg-laying birds, milch animals ...

Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ciprofloxacin is still imported. Moreover, most of those imports, whether ...

New Delhi: The value of mobile phone production in India has seen a sharp rise of around 146%, increasing from ₹2,13,773 ...

Antibiotic use in infancy could leave lasting damage to immune defenses, according to new research from the University of ...

TOKYO -- Japanese pharmaceutical companies are ramping up investment to build a domestic supply chain for antibiotics, fueled by government subsidies designed to reduce the nation's reliance on China ...

Lyfius Pharma resumes Penicillin-G production at Kakinada plant after fire incident, receives APPCB approval to operate.

Patients in the UK will now be able to access advanced, personalized treatments prepared at the hospital or even in mobile ...

Aurobindo Pharma has resumed its Penicillin-G production at its Kakinada facility in Andhra Pradesh through its subsidiary, Lyfius Pharma, following the receipt of the ''Consent to Operate'' (CTO) ...